SEC Form 4 · accession 0001645627-17-000085
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 23, 2017
Accepted (ET)
Jun 26, 2017 · 1:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 23, 2017 | P | 1,000 | $0.0524 | A | 21,334,349 | D | |
| Common Stock | Jun 23, 2017 | P | 1,000 | $0.053 | A | 21,335,349 | D | |
| Common Stock | Jun 23, 2017 | P | 1,000 | $0.053 | A | 21,336,349 | D | |
| Common Stock | Jun 23, 2017 | P | 1,000 | $0.053 | A | 21,337,349 | D |
Table II — derivative securities
No Table II lines on this filing.